AstraZeneca concludes acquisition of TeneoTwo Ruchika Sharma15 Aug 2022 11:00 AM ISTAstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
Pfizer to purchase Global Blood Therapeutics for USD 5.4 Billion Ruchika Sharma9 Aug 2022 12:44 PM ISTNew York: Pfizer Inc. and Global Blood Therapeutics, Inc. have announced the companies have entered into a definitive agreement under which...
Gilead Sciences to acquire MiroBio for Rs 3225 crore Ruchika Sharma9 Aug 2022 11:00 AM ISTThe acquisition will provide Gilead with MiroBio's proprietary discovery platform and entire portfolio of immune inhibitory receptor agonists.
Amgen to acquire ChemoCentryx for USD 4 billion in cash Ruchika Sharma7 Aug 2022 2:15 PM ISTThousand Oaks: Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune...
Cipla EU to acquire additional 19.16 percent stake in Cipla Maroc Ruchika Sharma6 Aug 2022 5:15 PM ISTNew Delhi: Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, ...
Dr Reddy's Labs to acquire Slayback Pharma OTC ophthalmic product rights Ruchika Sharma30 July 2022 4:07 PM ISTSlayback Pharma is the first company to file an ANDA for the private label equivalent for Lumify with the USFDA under Paragraph IV certification.
Cipla Health to acquire Endura Mass from Medinnbelle Hervalcare Rahul Verma15 July 2022 4:58 PM ISTCipla Limited has announced that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive...
Cipla to buy nutritional supplement brand Endura Mass Ruchika Sharma15 July 2022 1:00 PM ISTThis acquisition is in line with Cipla's strategic imperative to augment the Company's wellness portfolio for bringing about a shift from an illness...
Cipla to purchase additional stake in GoApptiv for Rs 26 crore Ruchika Sharma28 Jun 2022 2:00 PM ISTThe company's earlier investment in GoApptiv in June 2020 has yielded growth and expanded Cipla's channel reach across lower tier towns in India.
Aurobindo Pharma buys 51 percent stake in GLS Pharma Ruchika Sharma20 Jun 2022 4:55 PM ISTHyderabad: Aurobindo Pharma has recently announced that the Board of Directors of the Company has approved the acquisition of 51% equity shares in...
Pfizer to acquire 8.1 percent stake in Valneva Ruchika Sharma20 Jun 2022 10:30 AM ISTValneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.
Cipla to purchase 21.05 percent stake in Achira Labs to develop affordable medical kits in India Ruchika Sharma18 Jun 2022 11:22 AM ISTMumbai: Cipla Limited has announced that the company has signed definitive agreements for acquisition of 21.05% stake (on a fully diluted basis) for...
